Global Assets Advisory »

Crispr Therapeutics shares owned by Global Assets Advisory

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Global Assets Advisory from 13F filings

Historical chart of Global Assets Advisory investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Global Assets Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Global Assets Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $228k 4.4k 52.44

More positions owned by Global Assets Advisory

NVIDIA Corporation (NVDA)
Apple (AAPL)
Exxon Mobil Corporation (XOM)
Amazon (AMZN)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr Core Us Aggbd Et (AGG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Series Trust State Street Spd (SJNK)
Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Dimensional Intl (DXIV)

View all positions for Global Assets Advisory

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital Research and Management Company - Division 3
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Geode Capital Management
Susquehanna International
Sr One Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics